08.05.2017 16:00, Tsering Ngorkhangsar
Leaving to Boston on June 11 until June 17, this year’s venture leaders Life Science forming the ‘Swiss National Startup Team Life Science 2017’ reflect the impressive quality of Swiss startups, whose innovations come from the best universities and research institutes of Switzerland. Learn more about their growth objectives before the trip in our short interview series, running from May 9 to May 22 on venturelab.ch, Facebook, Twitter and LinkedIn.
You can see the whole campaign on
twitter.com/venturelab_ch searching the hashtag
#vleadersLifeScience.
Comphya is developing an active implantable medical device to restore erectile function of patient non-responsive to oral drugs.
Why do you choose Boston as your business development destination?
Boston has a unique and effective ecosystem for Life Science venture. It is an ideal destination for fundraising.
What do you want to achieve from the trip?
Set initial investor contact for “serie A” investment. Also, I want to better understand the environment for manufacturer partnership in the US, since most of our potential partners are located there.
Why is venture leaders Life Science really beneficial for your company?
We will expose our company to investors of the Boston area. Also, after the roadshow we will better understand the environment for partnership (manufacturers and distributors).